Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.01 USD
Change Today 0.00 / 0.00%
Volume 0.0
LTUS On Other Exchanges
As of 8:10 PM 11/23/15 All times are local (Market data is delayed by at least 15 minutes).

lotus pharmaceuticals inc (LTUS) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/9/15 - $0.02
52 Week Low
12/31/14 - $0.0060
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

lotus pharmaceuticals inc (LTUS) Related Businessweek News

No Related Businessweek News Found

lotus pharmaceuticals inc (LTUS) Details

Lotus Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceuticals in the People’s Republic of China. The company markets valsartan capsules under the Maixin name to treat hypertension; eye drops under the Muxin name to treat glaucoma; and Octreotide Acetate Injection solution under the Yipubishan name for treating gastric ulcers. It also offers Junxin branded Levofloxacin, an anti-bacterial drug for the treatment of mild, moderate, and severe infections caused by susceptible trains of the designated microorganisms in the conditions such as acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections, complicated and uncomplicated urinary tract infections, and acute pyelonephritis; and Nicergoline for Injection, an a-receptor blockage nerve system blood-brain medicine. The company's products under development include R-Bambuterol-Class 1 for the treatment of asthma; Gliclazide-controlled release tablets for the treatment of diabetes; Isosorbide Mononitrate-tablets for the treatment of cardiovascular-coronary artery; Verapamil Hydrochloride tablets for the treatment of cardiovascular-irregular angina; and Lovastatin tablets, Valsartan-controlled release tablets, and Hawthorn Flavonoids tablets for the treatment of cardiovascular-hyperlipemia. It also involves in retailing Western and traditional Chinese medications, and medical treatment equipment through 10 retail pharmacy locations; performing research and development, and lab testing projects for third parties; and leasing retail space to licensed physicians, and merchants in the retail pharmacies. The company sells its products through a nationwide sales network to hospitals, clinics, and drugs stores. Lotus Pharmaceuticals, Inc. is based in Beijing, the People’s Republic of China.

233 Employees
Last Reported Date: 03/28/11

lotus pharmaceuticals inc (LTUS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LTUS:US $0.01 USD 0.00

LTUS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LTUS.
View Industry Companies

Industry Analysis


Industry Average

Valuation LTUS Industry Range
Price/Earnings 0.2x
Price/Sales 0.0x
Price/Book 0.0x
Price/Cash Flow 0.2x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LOTUS PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at